140 related articles for article (PubMed ID: 19062221)
21. Biomarker discovery from body fluids using mass spectrometry.
Villar-Garea A; Griese M; Imhof A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
[TBL] [Abstract][Full Text] [Related]
22. New drugs in multiple myeloma.
Berenson JR; Yellin O
Curr Opin Support Palliat Care; 2008 Sep; 2(3):204-10. PubMed ID: 18685422
[TBL] [Abstract][Full Text] [Related]
23. Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14 C-bortezomib.
Hemeryck A; Geerts R; Monbaliu J; Hassler S; Verhaeghe T; Diels L; Verluyten W; van Beijsterveldt L; Mamidi RN; Janssen C; De Coster R
Cancer Chemother Pharmacol; 2007 Nov; 60(6):777-87. PubMed ID: 17285316
[TBL] [Abstract][Full Text] [Related]
24. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience.
Engel RH; Brown JA; Von Roenn JH; O'Regan RM; Bergan R; Badve S; Rademaker A; Gradishar WJ
Cancer Invest; 2007 Dec; 25(8):733-7. PubMed ID: 17952740
[TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristics of velcade cumulative effect in resistant and recurrent multiple myeloma].
Mitina TA; Golenkov AK
Ter Arkh; 2008; 80(7):48-50. PubMed ID: 18763595
[TBL] [Abstract][Full Text] [Related]
27. Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry.
Aresta A; Calvano CD; Palmisano F; Zambonin CG; Monaco A; Tommasi S; Pilato B; Paradiso A
J Pharm Biomed Anal; 2008 Jan; 46(1):157-64. PubMed ID: 18035512
[TBL] [Abstract][Full Text] [Related]
28. Use of intrapleural bortezomib in myelomatous pleural effusion.
Iannitto E; Minardi V; Tripodo C
Br J Haematol; 2007 Nov; 139(4):621-2. PubMed ID: 17979947
[No Abstract] [Full Text] [Related]
29. Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers.
de Roos B; Geelen A; Ross K; Rucklidge G; Reid M; Duncan G; Caslake M; Horgan G; Brouwer IA
Proteomics; 2008 May; 8(10):1965-74. PubMed ID: 18491311
[TBL] [Abstract][Full Text] [Related]
30. Immune-mediated neuropathies in myeloma patients treated with bortezomib.
Ravaglia S; Corso A; Piccolo G; Lozza A; Alfonsi E; Mangiacavalli S; Varettoni M; Zappasodi P; Moglia A; Lazzarino M; Costa A
Clin Neurophysiol; 2008 Nov; 119(11):2507-12. PubMed ID: 18829381
[TBL] [Abstract][Full Text] [Related]
31. Characterization of E. coli ribosomal particles : combined analysis of whole proteins by mass spectrometry and of proteolytic digests by liquid chromatography-tandem mass spectrometry.
Iost I; Charollais J; Vinh J; Pflieger D
Methods Mol Biol; 2008; 432():321-41. PubMed ID: 18370028
[TBL] [Abstract][Full Text] [Related]
32. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.
Chng WJ; Kumar S; Vanwier S; Ahmann G; Price-Troska T; Henderson K; Chung TH; Kim S; Mulligan G; Bryant B; Carpten J; Gertz M; Rajkumar SV; Lacy M; Dispenzieri A; Kyle R; Greipp P; Bergsagel PL; Fonseca R
Cancer Res; 2007 Apr; 67(7):2982-9. PubMed ID: 17409404
[TBL] [Abstract][Full Text] [Related]
33. Novel truncated isoforms of constitutive serum amyloid A detected by MALDI mass spectrometry.
Farwig ZN; McNeal CJ; Little D; Baisden CE; Macfarlane RD
Biochem Biophys Res Commun; 2005 Jul; 332(2):352-6. PubMed ID: 15910745
[TBL] [Abstract][Full Text] [Related]
34. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS).
Yin P; Zhao X; Li Q; Wang J; Li J; Xu G
J Proteome Res; 2006 Sep; 5(9):2135-43. PubMed ID: 16944924
[TBL] [Abstract][Full Text] [Related]
35. Aqueous two-phase partitioning for proteomic monitoring of cell surface biomarkers in human peripheral blood mononuclear cells.
Everberg H; Peterson R; Rak S; Tjerneld F; Emanuelsson C
J Proteome Res; 2006 May; 5(5):1168-75. PubMed ID: 16674106
[TBL] [Abstract][Full Text] [Related]
36. Detection and identification of plasma proteins that bind GlialCAM using ProteinChip arrays, SELDI-TOF MS, and nano-LC MS/MS.
Favre-Kontula L; Sattonnet-Roche P; Magnenat E; Proudfoot AE; Boschert U; Xenarios I; Vilbois F; Antonsson B
Proteomics; 2008 Jan; 8(2):378-88. PubMed ID: 18203261
[TBL] [Abstract][Full Text] [Related]
37. Identification of oxidative post-translational modification of serum albumin in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension of sickle cell anemia.
Odhiambo A; Perlman DH; Huang H; Costello CE; Farber HW; Steinberg MH; McComb ME; Klings ES
Rapid Commun Mass Spectrom; 2007; 21(14):2195-203. PubMed ID: 17569101
[TBL] [Abstract][Full Text] [Related]
38. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system.
Misek DE; Kuick R; Wang H; Galchev V; Deng B; Zhao R; Tra J; Pisano MR; Amunugama R; Allen D; Walker AK; Strahler JR; Andrews P; Omenn GS; Hanash SM
Proteomics; 2005 Aug; 5(13):3343-52. PubMed ID: 16047307
[TBL] [Abstract][Full Text] [Related]
39. Searching for novel biomarkers of centrally and peripehrally-acting neurotoxicants, using surface-enhanced laser desorption/ionisation-time-of-flight mass spectrometry (SELDI-TOF MS).
Fang M; Boobis AR; Edwards RJ
Food Chem Toxicol; 2007 Nov; 45(11):2126-37. PubMed ID: 17602814
[TBL] [Abstract][Full Text] [Related]
40. A novel approach and protocol for discovering extremely low-abundance proteins in serum.
Tanaka Y; Akiyama H; Kuroda T; Jung G; Tanahashi K; Sugaya H; Utsumi J; Kawasaki H; Hirano H
Proteomics; 2006 Sep; 6(17):4845-55. PubMed ID: 16878292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
